Citation: | PENG Xuehan, XIE Wenmin, LI Ji, YU Feng. Comparative investigation of in vitro antitumor activity of Ganoderma lucidum spore oil[J]. Journal of China Pharmaceutical University, 2019, 50(1): 81-86. DOI: 10.11665/j.issn.1000-5048.20190111 |
[1] |
Cör D,Knez Ž,Knez Hrni M.Antitumour,antimicrobial,antioxidant and antiacetylcholinesterase effect of Ganoderma lucidum terpenoids and polysaccharides:a review[J].Molecules,2018,23(3):183-197.
|
[2] |
Boh B,Berovic M,Zhang J,et al.Ganoderma lucidum and its pharmaceutically active compounds[J].Biotechnol Annu Rev,2007,13(2):265-301.
|
[3] |
Hajjaj H,Mace C,Roberts M,et al.Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors[J].Appl Environ Microbiol,2005,71(7):3653-3678.
|
[4] |
Suarez-Arroyo IJ, Rosario-Acevedo R, Aguilar-Perez A, et al. Anti-tumor effects of Ganoderma lucidum(reishi)in inflammatory breast cancer in in vivo and in vitro models[J].PLoS One,2013,8(2):457-481.
|
[5] |
Yuen J, Gohel M. Anticancer effects of Ganoderma lucidum:a review of scientific evidence[J].Nutr Cancer,2005,53(1):11-17.
|
[6] |
Yue G, Chan B, Han X, et al. Immunomodulatory activities of Ganoderma sinense polysaccharides in human immune cells[J].Nutr Cancer,2013,65(5):765-774.
|
[7] |
Akinyemiju T,Abera S,Ahmed M,et al.The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global,regional,and national level:results from the global burden of disease study 2015[J].JAMA Oncol,2017,3(12):1683-1691.
|
[8] |
Vilmar A,Sorensen J.Customising chemotherapy in advanced nonsmall cell lung cancer:daily practice and perspectives[J].Eur Respir Rev,2011,20(119):45-52.
|
[9] |
Testa U,Pelosi E,Castelli G.Colorectal cancer:genetic abnormalities,tumor progression,tumor heterogeneity,clonal evolution and tumor-initiating cells[J].Med Sci(Basel),2018,6(2):336-351.
|
[10] |
Qu D,He J,Liu C,et al.Triterpene-loaded microemulsion using Coix lacryma-jobi seed extract as oil phase for enhanced antitumor efficacy:preparation and in vivo evaluation[J].Int J Nanomedicine,2014,9(5):109-119.
|
[11] |
Ben-Neriah Y,Karin M.Inflammation meets cancer,with NF-kappaB as the matchmaker[J].Nat Immunol,2011,12(8):715-723.
|
[12] |
Disis M.Immune regulation of cancer[J].J Clin Oncol,2010,28(29):4531-4538.
|
[13] |
Smyth M,Dunn G,Schreiber R.Cancer immunosurveillance and immunoediting:the roles of immunity in suppressing tumor development and shaping tumor immunogenicity[J].Adv Immunol,2006,90(4):1-50.
|
[14] |
Liu Y,Zhou G,Wang Z,et al.NF-kappaB signaling is essential for resistance to heat stress-induced early stage apoptosis in human umbilical vein endothelial cells[J].Sci Rep,2015,5(2):135-147.
|
[15] |
Nicholson D,Thornberry N.Caspases:killer proteases[J].Trends Biochem Sci,1997,22(8):299-306.
|
[16] |
Porter A,Ng P,Janicke R.Death substrates come alive[J].Bioessays,1997,19(6):501-507.
|
[17] |
Devarajan E,Sahin A,Chen J,et al.Down-regulation of caspase 3 in breast cancer:a possible mechanism for chemoresistance[J].Oncogene,2002,21(57):8843-8851.
|
[18] |
Xue Y,Wu L,Liu Y,et al.ENTPD5 induces apoptosis in lung cancer cells via regulating caspase 3 expression[J].PLoS One,2015,10(3):2012-2046.
|
[19] |
Lin J, Zhang Y, Wang H, et al. Genetic polymorphisms in the apoptosis-associated gene casp3 and the risk of lung cancer in chinese population[J].PLoS One,2016,11(10):4016-4158.
|